COMMUNIQUÉS West-GlobeNewswire

Precision Neuroscience Unveils a New Map of the Human Nervous System
08/10/2026
A uniquely large dataset spanning cortex, brainstem, and spinal cord in 70 patients—released as the Precision system passes its 100th patient implant NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience [...]
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
08/10/2026
Continued participation underscores commitment to expanding options for patients referred to fertility centers under the care of reproductive endocrinologists ATLANTA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. ( [...]
Solera Health Launches Cancer Care Network to Connect Members to Digital Cancer Screening, Supportive Care and Treatment Navigation
08/10/2026
Network pairs Iris by OncoHealth® and Fuze Health to support members across their journey, from early detection through care navigation PHOENIX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Solera Health , the premier digital [...]
Fieldstone Bio Selected for Rio Tinto and Founders Factory Mining Tech Accelerator
08/10/2026
Investment marks Fieldstone's first backing from the mining industry WOBURN, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Fieldstone Bio , a synthetic biology company building a new class of critical-mineral biosensors, [...]
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
08/10/2026
Medical Director Annie Thurman, MD, FACOG to present adverse event and relative bioavailability data comparing topical Sildenafil Cream with oral sildenafil in healthy male adults SAN DIEGO, Oct. 08, 2026 (GLOBE [...]
Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body
08/10/2026
Submission seeks to extend the Ameluz ® label beyond the face and scalp to treatment fields of up to approximately 240 cm² on the rest of the body, with an adjusted illumination protocol WOBURN, Mass., Oct. 08, 2026 ( [...]
World Spine Day 2026: Small Changes Can Make a Big Difference
08/10/2026
Experience Better Back Health PLANO, Texas, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Dallas Neurosurgical & Spine doctors Jeremy Denning , MD, and Krishna Satyan , MD, are gearing up for World Spine Day, by providing tips [...]
Sienna Announces Third Quarter 2026 Results Release Date and Conference Call
08/10/2026
MARKHAM, Ontario, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2026 third quarter results after market close on Thursday, [...]
HealthTab™ and HeartEye Open New Referral Pathway into Community Pharmacy
08/10/2026
VANCOUVER, British Columbia, Oct. 08, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) is pleased to announce that its wholly owned subsidiary, HealthTab Ltd. (“HealthTab”), has [...]
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
08/10/2026
CALGARY, Alberta, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF ), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug [...]
Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution
08/10/2026
First-Quarter Results Reinforce Tilray’s Progress Converting Global Scale, Disciplined Execution and Category Leadership into Higher Revenue, Expanded Gross Profit and Continued Momentum Record First-Quarter Net Revenue [...]
Gain Therapeutics to Attend the 2026 Maxim Growth Summit
08/10/2026
BETHESDA, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia
08/10/2026
CAMBRIDGE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T [...]
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
08/10/2026
Leadership investment supports expanded hospital commercial push POMPANO BEACH, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative [...]
Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program
08/10/2026
Management call today at 3.30 pm CEST Newron received the anticipated FDA written communication on clinical hold at U.S. study centers and is reviewing feedback and preparing its response ENIGMA-TRS 1 enrollment [...]
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
08/10/2026
Phase 1/2 clinical trial of EDIT-401 cleared to initiate dosing in patients who require additional LDL-C lowering Company remains on track to begin patient dosing this year and report initial safety and tolerability [...]
Agios to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5 at 8:00 a.m. ET
08/10/2026
CAMBRIDGE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, [...]
What Actually Keeps Weight Off After a Weight Loss Program
08/10/2026
Baltimore, MD, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Weight regain after initial weight loss is a recognized pattern among individuals pursuing lasting metabolic change. Trilivy™, a science-backed, coach-guided metabolic [...]
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
08/10/2026
New criteria fully approved at nine of eleven active sites expected to significantly accelerate enrollment pace Initial readout timing to be updated by year-end based on demonstrated Q4 enrollment increases Overall [...]

Pages